This trial is completed!
Search for a recruiting clinical trial for your condition
Your journey
1What's a trial
4Get in touch
More info
You can access this
clinical trial
if you have
Parkinson Disease or Alzheimer Disease
and you are
between 18 and 90
years old
This is an early phase trial to determine
the dosage and safety of the new treatment.
Show me locations

The purpose

The underlying goal of this study is to assess [18F] CFPyPB PET imaging as a tool to evaluate the activity of the GlyT1 receptors in the brain of Parkinson's Disease (PD) and Alzheimer Disease (AD) research participants.

Provided treatments

  • Drug: [18F] CFPyPB

Locations near you

Unfortunately, there are no recruiting locations near you. Please check the list with all locations below.
Tris trial is registered with FDA with number: NCT01461109. The sponsor of the trial is Institute for Neurodegenerative Disorders and it is looking for 4 volunteers for the current phase.
Official trial title:
Evaluation of [18F] CFPyPB PET as a Marker of Glycine Transporter-1 (GlyT1) Receptor in Subjects With Parkinson Disease, Alzheimer Disease and Healthy Subjects